Osmol Therapeutics Appoints Christopher S. Eklund to its Board of Directors
15 May 2024 //
GLOBENEWSWIRE
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer
04 Mar 2024 //
GLOBENEWSWIRE
FDA Notifies Osmol that the First-in-Human Phase 1 Clinical Trial of OSM-0205
18 Sep 2023 //
BUSINESSWIRE
Osmol Appoints Teresa Bitetti at Takeda to the Board of Directors
08 Sep 2022 //
BUSINESSWIRE
Osmol Closes Series A-1 Funding to Prevent Chemotherapy-Induced Neuropathy
12 Apr 2022 //
BUSINESSWIRE